Eating Behavior Strategies for Childhood Obesity
Trial Summary
What is the purpose of this trial?
This study aims to determine the relationships among loss of control eating, restriction, relative reinforcing value of high energy-dense food, and obesity risk. In order to achieve this aim, the investigators will follow children over the course of a year, obtaining behavioral and observational measurements, in addition to a two-week restricted access and two week non-restricted access period.
Will I have to stop taking my current medications?
If your child is taking medications that affect appetite, such as Ritalin, Adderall, Concerta, Wellbutrin, or Prednisone, they will not be able to participate in the study.
What data supports the effectiveness of the treatment Eating Behavior Strategies for Childhood Obesity?
Research suggests that time-limited eating (TLE), a component of the treatment, may be effective for managing obesity in children. TLE is seen as feasible and potentially more effective than other methods because it simplifies eating patterns by focusing on eating within a specific time frame, which can help reduce weight without affecting growth.12345
Is time-restricted feeding safe for humans, including children, with obesity?
Research suggests that time-restricted feeding, where food is consumed within a specific time window, is generally safe for adults with obesity, as no adverse events were reported in a study. However, there is limited safety data specifically for children, though it is considered potentially more feasible and less stigmatizing than other dietary approaches.12367
How does the treatment in the Eating Behavior Strategies for Childhood Obesity trial differ from other treatments for childhood obesity?
This treatment uses Time-Limited Eating (TLE), which is unique because it focuses on eating within a specific time window rather than counting calories or restricting certain foods. This approach is potentially more flexible and less stigmatizing for children, making it easier for them to follow compared to traditional methods that require constant monitoring of food intake.128910
Research Team
Katherine Balantekin, PhD, RD
Principal Investigator
Clinical Associate Professor
Eligibility Criteria
This trial is for children aged 8-11 who are at risk for obesity or already obese, partly based on their own BMI or their parent's weight. They must enjoy at least half of the study foods and eat them twice a week. Kids with clinical eating disorders, allergies to study foods, not liking most study foods, or taking appetite-affecting meds can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete consent, height/weight/body fat measurements, questionnaires, and tasks including delayed discounting and relative reinforcing value tasks.
Randomized Cross-over Design
Participants undergo two weeks of restricted access and two weeks of non-restricted access, with a one-week washout period in between, including loss of control test meals.
Follow-up
Participants are monitored for changes in zBMI and body fat percentage, with follow-up visits at 6 and 12 months for measurements and tasks.
Treatment Details
Interventions
- Non-Restricted Access Period
- Restricted Access Period
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator